Source:http://linkedlifedata.com/resource/pubmed/id/20160079
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2010-3-3
|
pubmed:abstractText |
Substance P (SP) is a proinflammatory mediator implicated in inflammatory bowel disease (IBD) and other inflammatory states. SP acts by stimulating the neurokinin-1 receptor (NK-1R) on T lymphocytes and other cell types, and regulates these cells in a complex interplay with multiple cytokines. The mechanisms of interaction among these inflammatory mediators are not yet fully understood. Here, we demonstrate that function of the NK-1R, a member of the G protein-coupled receptor (GPCR) superfamily, is modulated by TGF-beta. The latter acts not on a GPCR but via serine-threonine kinase-class receptors. By flow confocal image analysis, we demonstrate that TGF-beta delays SP-induced NK-1R internalization on mucosal T cells isolated from a mouse model of IBD and on granuloma T cells in murine schistosomiasis. Furthermore, luciferase reporter-gene assays revealed that NK-1R stimulation activates the nuclear factor of activated T cell- and activator protein-1-dependent signaling pathways, which are known triggers of effector T-cell cytokine production. TGF-beta markedly increases SP-induced activation of these signaling cascades, suggesting that delayed NK-1R internalization results in enhanced signaling. Providing a link to amplified immune function, SP and TGF-beta, when applied in combination, trigger a strong release of the proinflammatory cytokines IFN-gamma and IL17 from intestinal inflammatory T cells, whereas either agonist alone shows no effect. These observations establish precedent that members of two distinct receptor superfamilies can interact via a previously unrecognized mechanism, and reveal a paradigm of GPCR transregulation that is relevant to IBD and possibly other disease processes.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1091-6490
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
2
|
pubmed:volume |
107
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4293-8
|
pubmed:dateRevised |
2010-9-3
|
pubmed:meshHeading |
pubmed-meshheading:20160079-Animals,
pubmed-meshheading:20160079-Cell Line,
pubmed-meshheading:20160079-Endocytosis,
pubmed-meshheading:20160079-Flow Cytometry,
pubmed-meshheading:20160079-Humans,
pubmed-meshheading:20160079-Inflammatory Bowel Diseases,
pubmed-meshheading:20160079-Interleukin-10,
pubmed-meshheading:20160079-Mice,
pubmed-meshheading:20160079-Mice, Inbred C57BL,
pubmed-meshheading:20160079-Microscopy, Confocal,
pubmed-meshheading:20160079-Receptors, Neurokinin-1,
pubmed-meshheading:20160079-Signal Transduction,
pubmed-meshheading:20160079-Substance P,
pubmed-meshheading:20160079-T-Lymphocytes,
pubmed-meshheading:20160079-Transforming Growth Factor beta
|
pubmed:year |
2010
|
pubmed:articleTitle |
TGF-beta regulates T-cell neurokinin-1 receptor internalization and function.
|
pubmed:affiliation |
Division of Gastroenterology and Hepatology, Department of Internal Medicine, and Molecular Pharmacology Research Center, Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|